The brightening future of HIV therapeutics (Q35873262)

10 August 2017

1 reference

title

The brightening future of HIV therapeutics (English)

1 reference

10 August 2017

Warner C Greene

1

1 reference

PubMed ID

15334078

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

9

1 reference

10 August 2017

867-871

1 reference

The entry of entry inhibitors: a fusion of science and medicine

10 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Antiviral drugs in current clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Can the use of HIV-1 derived gene transfer vectors for clinical application be justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Structure and function of HIV-1 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Latency in human immunodeficiency virus type 1 infection: no easy answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0904-867

21 January 2018

Identifiers

DOI

10.1038/NI0904-867

1 reference

10 August 2017

1 reference

PubMed ID

15334078